Hanaa El Gendy
Cairo, Ain Shams University Specialized Hospital, Egypt
NCT Number: NCT04408768
Whereas diabetes mellitus is clearly a risk factor for the occurrence of stroke and for its poor prognosis, hyperglycemia per se is also linked to increased morbidity and mortality in stroke patients.Therefore, the objective of this work was to study the glycemic status of acute ischemic stroke patients and to assess its impact on stroke outcome.
Looking for future studies?
Notify Me50 year–70 year
All sexes
Observational
Cairo, Ain Shams University Specialized Hospital, Egypt
Using PASS program, setting alpha error at 5% and power of 80%, the total sample size was estimated to be 80 cases.
The NIHSS was used as a primary outcome; 40 cases were needed in each group. Secondary outcomes were hemorrhagic transformation, hospital stay duration, mechanical ventilation, need for vasopressors, and 30-days mortality.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Standard protocol for stroke patients
Other names: no specific intervention
Time frame: 30 days
The NIHSS score categorized into: no stroke symptoms (0), mild stroke (1-4), moderate stroke (5-15), moderate to severe stroke (16-20), and sever (21-42)
Time frame: 30 days
Hemorrhagic transformation, the length of hospital stay, need for mechanical ventilation and vasopressors and 30-days mortality
Ain Shams University
Other
Stress Hyperglycemia as a Prognostic Factor in Acute Ischemic Stroke Patients
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01969149
Stress Hyperglycemia
Besançon, France
View Trial DetailsNCT02726958
Stress Hyperglycemia
Besançon, France
View Trial DetailsNCT02847104
Stress Hyperglycemia
View Trial DetailsNCT07662980
Diabetes Mellitus, Endocrine System Diseases
Calgary, Alberta, Canada
View Trial Details